Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Optimizing pediatric periprocedural pain management part II—Adjunct therapies to support the use of infiltrative anesthetics
Henkel, Emily , Haller, Courtney N. , Diaz, Lucia Z., Ricles, Victoria , Grossman, Ashley V. Wong, Krakowski, Andrew C. , Wong Grossman, Ashley V, Nemergut, Michael E. , Grossman, Ashley Wong

Pediatric Dermatology | July 5, 2024 | Volume: 41 | Issue: 4 | Pages: 588-598

10.1111/pde.15677 | PMID 38965874 Get It

AbstractPediatric procedure‐related pain management is often incompletely understood, inadequately addressed, and critical in influencing a child's lifelong relationship with the larger healthcare community. We present a comprehensive review of infiltrative anesthetics, including a comparison of their mechanisms of action and relative safety and efficacy data to help guide clinical selection. We also describe the multimodal utilization of adjunct therapies—in series and in parallel—to support the optimization of pediatric periprocedural pain management, enhance the patient experience, and provide alternatives to sedation medication and general anesthesia.
At what COST?: A prospective longitudinal cohort assessment of financial toxicity, quality of life, and associated risk factors in patients with plasma cell disorders
Warsame, Rahma , Schmidt, Walker M. , Dueck, Amylou C. , Dueck, A. C. , Warsame, Rahma , Dispenzieri, Angela , Dispenzieri, Angela

American Journal of Hematology | July 5, 2024 | Volume: 99 | Issue: 10 | Pages: 2029-2031

10.1002/ajh.27431 | PMID 38966949 Get It

Ulcerative erythematous papules and plaques on the face and lower legs of a man living with HIV: a clinicopathological challenge
McKenzie, Ning C. , Hickey, Matthew D. , Sancha, Carlo De la , Coates, Sarah J. , Leslie, Kieron

International Journal of Dermatology | July 5, 2024 | Volume: 63 | Issue: 11 | Pages: 1522-1524

10.1111/ijd.17362 | PMID 38965065 Get It

AbstractA 44‐year‐old male presented with a 2‐month history of erythematous ulcerative papules and plaques on the scalp, face, and bilateral lower legs. He had a 5‐year history of well‐controlled HIV on antiretroviral therapy and recurrent syphilis infections. His face had violaceous plaques, while bilateral ankles and calves had ulcerative lesions with necrotic centers and purple borders. The morphologies clinically mimicked pyoderma gangrenosum on the lower extremities and cutaneous lymphoma on the face. Biopsy and reactive rapid plasma reagin confirmed a diagnosis of lues maligna, and the patient was successfully treated with penicillin G benzathine.
Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestations
Shakhashiro, Muna , Sadeghian, Shadi, Newcomer, Jack , Marzano, Angelo Valerio , Maronese, Carlo Alberto , Newcomer, Jack B. , Maronese, Carlo A , Sadeghian, Shadi, Davis, John M. , Alavi, Afsáneh

International Journal of Dermatology | July 5, 2024 | Volume: 64 | Issue: 1 | Pages: 44-50

10.1111/ijd.17350 | PMID 38965064 Get It

AbstractYao syndrome (YAOS) is a novel systemic autoinflammatory disease linked to the nucleotide‐binding oligomerization domain (NOD2) gene. It is characterized by periodic fevers, gastrointestinal (GI) symptoms, arthritis, and dermatitis, among other symptoms. A sparse literature exists on this disease, and little is known about its dermatological manifestations. A review of available literature was performed to characterize the cutaneous manifestations of Yao syndrome. Cutaneous manifestations were documented in 85.7% of patients, with common characteristic descriptions of erythematous patches and plaques involving the face, trunk, abdomen, and extremities. Based on our review of treatment modalities employed for Yao syndrome, prednisone is an appropriate initial approach, with oral sulfasalazine and other disease‐modifying antirheumatic drugs serving as appropriate secondary options. YAOS should be considered in the differential diagnosis of patients presenting with a dermatitic rash, especially in the context of concurrent articular symptoms, periodic fever, and GI symptoms.
Spontaneous Simultaneous Bilateral Intraparenchymal Hemorrhage in a Child with Sickle Cell Disease
Valluzzi, Adelaide , Millesi, Elena , Lucchesi, Lucio, Palazzi, Giovanni, Cavalleri, Francesca, Rechberger, Julian S. , Iaccarino, Corrado , Pavesi, Giacomo

Journal of Pediatric Neurology | July 4, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0044-1787854 Get It

Clinical Characteristics and Mechanisms of Acute Myocarditis
Linthout, Sophie Van , Kraus, Sarah , Ntusi, Ntobeko , Heymans, Stephane , Van Linthout, Sophie , Kraus, Sarah Mignon , Cooper, Leslie T , Ntusi, Ntobeko A B , Heymans, Stéphane , Cooper, Leslie T.

Circulation Research | July 4, 2024 | Volume: 135 | Issue: 2 | Pages: 397-411

10.1161/circresaha.124.324674 | PMID 38963866 Get It

Myocarditis is defined by an immune response to infection or injury, most commonly identified after a viral infection or recent exposure to cardiotoxins or drugs. Classic myocarditis may also result from the activation of the immune system by self-antigens without an exogenous trigger. Pathogenic variants of genes encoding sarcolemmal and desmosomal proteins are present in 4% to 44% of myocarditis patients and may relate to persistent cardiac dysfunction and arrhythmias. The most common clinical presentation is acute chest pain resembling an ischemic infarction or pericarditis. Heart failure and syncope from tachy- or brady-arrhythmias are features of a complicated clinical course with substantial risk of future cardiovascular events and death. High-sensitivity troponin, ECG, and echocardiograms are useful but lack sufficient sensitivity and specificity to confirm the diagnosis. Cardiovascular magnetic resonance is indicated to confirm myocarditis in low-risk, uncomplicated cases. Endomyocardial biopsy is indicated to guide therapy in high-risk scenarios. In this review, we discuss the clinical aspects, pathogenesis, genetic susceptibility, and management of uncomplicated, complicated, and fulminant myocarditis related to viral injury. We identify gaps in understanding and suggest prime research questions in the pathogenesis, diagnosis, and treatment of acute myocarditis. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05335928.
Evaluation and management of knee osteoarthritis
Zhu, Siyi , Qu, Wenchun , He, Chengqi

Journal of Evidence-Based Medicine | July 4, 2024 | Volume: 17 | Issue: 3 | Pages: 675-687

10.1111/jebm.12627 | PMID 38963824 Get It

AbstractKnee osteoarthritis (KOA) significantly contributes to the global disability burden, with its incidence expected to escalate by 74.9% by 2050. The urgency to comprehend and tackle this condition is critical, necessitating an updated and thorough review of KOA. A systematic review up to February 26, 2024, has elucidated the principal aspects of KOA's pathogenesis, risk factors, clinical manifestations, and contemporary management paradigms. The origins of KOA are intricately linked to mechanical, inflammatory, and metabolic disturbances that impair joint function. Notable risk factors include age, obesity, and previous knee injuries. Diagnosis predominantly relies on clinical assessment, with radiographic evaluation reserved conditionally. The significance of rehabilitation assessments, informed by the International Classification of Functioning, Disability, and Health framework, is highlighted. Treatment strategies are diverse, prioritizing nonpharmacological measures such as patient education, exercise, and weight management, with pharmacological interventions considered adjuncts. Intra‐articular injections and surgical options are contemplated for instances where conventional management is inadequate. KOA stands as a predominant disability cause globally, characterized by a complex etiology and profound effects on individuals’ quality of life. Early, proactive management focusing on nonpharmacological interventions forms the cornerstone of treatment, aiming to alleviate symptoms and enhance joint function. This comprehensive review underscores the need for early diagnosis, individualized treatment plans, and the integration of rehabilitation assessments to optimize patient outcomes. Further research is needed to refine prevention strategies and improve management outcomes for KOA patients.
Time will heal: a case of resolved central sleep apnea
Tu, Xinhang , Caples, Sean M., Gay, Peter C. , Caples, Sean, Gay, Peter

Journal of Clinical Sleep Medicine | July 4, 2024 | Volume: 20 | Issue: 10 | Pages: 1711-1715

10.5664/jcsm.11284 | PMID 38963066 Get It

Adult Brachial Plexus Injuries: Treatment in the Acute Phase
Rodriguez, Maria Cristina, Shin, Alexander Y.

Cirugía de Mano y Microcirugía | July 4, 2024 | Volume: 3 | Issue: 1 | Pages: No page available

10.25214/28056272.1678 Get It

Brachial Plexus Injuries are a catastrophic situation that affects patients on many levels. While many treatment options are discussed in the literature, general treatment principles should be applied, especially in the acute phase. In addition to the surgeon's expert knowledge of anatomy and injury characteristics, education of the patient concerning the ramifications of their injury and providing clear expectations of realistic outcomes are imperative for both the surgeon and the patient. A review of the principles of acute surgical treatment will be presented.
Reconstruction of Palatal Defects Using a Composite Chondromucosal Nasoseptal Flap and Comparative Analysis
Bon‐Nieves, Antonio , Peraza, Lazaro R. , Ortiz‐Correa, Zinnarky K., Pinheiro‐Neto, Carlos , Bon-Nieves, Antonio A , Pinheiro-Neto, Carlos D , Price, Daniel L.

The Laryngoscope | July 4, 2024 | Volume: 134 | Issue: 12 | Pages: 4882-4887

10.1002/lary.31621 | PMID 38963264 Get It

ObjectiveThe use of composite chondromucosal nasal septal flaps (ccNSF) has been demonstrated to be effective in cadaveric studies for the anterior skull base and the orbit. However, their application in the clinical setting remains unexplored. Our study aims to introduce a new method for treating palatal defects using ccNSF. Additionally, we studied the average NSF area and compared it to the average palate area.MethodsWe collected 108 CT scans from the medical records of patients without head and neck pathologies from a tertiary medical institution. We quantified the quadrangular (septal) cartilage and palate areas. Furthermore, we included a clinical case in which we used the ccNSF for the palatal defect reconstruction. This was to compare the mean area between the palate and the septal cartilage.ResultsThe ccNSF covered the palatal defect without any significant complications for the first 9 months of follow‐up. A total of 102 CT scans met the inclusion criteria and were measured. We found that the mean quadrangular cartilage had a length of 2.50 (±0.52) cm, a width of 2.28 (±0.51) cm, and an area of 5.43 (±1.68) cm2. The mean palate length was 2.73 (±0.44) cm, with a width of 3.13 (±0.34) cm, and area of 7.87 (±1.43) cm2.ConclusionsThe ccNSF proved successful in palatal defect reconstruction, resulting in positive outcomes and no major complications until the 9‐month follow‐up. The ccNSF is a useful flap that avoids the use of free flap transfer and its associated morbidities.Level of Evidence4 Laryngoscope, 134:4882–4887, 2024